FDA advisers reject psychedelic party drug MDMA to treat PSTD in adults
The advisory committee of the US Food and Drug Administration has rejected a therapy using party drug MDMA, or ecstasy or molly to
The advisory committee of the US Food and Drug Administration has rejected a therapy using party drug MDMA, or ecstasy or molly to
AstraZeneca announced the completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, for $2.4 billion.
Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or
Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer
British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a
HQ Team June 3, 2024: An antibody-drug conjugate, jointly being developed by AstraZeneca and Daiichi Sankyo, has been shown in end-stage clinical trials
Negotiations at reaching a global accord to help fight pandemics better will conclude by 2025 or “earlier if possible at a special session
Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression
Eighteen million people are “acutely” hungry in conflict-ridden Sudan as a famine is on the horizon and 800,000 civilians get ready for large-scale
Technology-based medical training has led to junior doctors avoiding the ward to stick to the electronic tablet — a healthcare crisis that will